Interestingly, TP53 alterations in AML are associated with distinct genomic and biological characteristics, such as complex karyotype and increased genomic instability, which correlate with poor prognosis (Haferlah et al, 2008; Rücker et al, 2012). The gene discussed is TP53; the disease is acute myeloid leukemia.